GlassScriptPhysician profile
Babar Khan
NPI 1487038477
$8,076.89
in general payments reported to CMS, 2019-2025
22 companies · $1,268 in 2025
The $1,268 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $183 · 2022: $1,991 · 2023: $937 · 2024: $3,698 · 2025: $1,268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,555 · Travel and Lodging: $2,348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,554.88 |
| Travel and Lodging | $2,348.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,201.30 | 2022-2025 | Micra, Onyx Frontier, Cobalt Dr Mri Surescan |
| Abbott Laboratories | $2,387.39 | 2022-2025 | Aveir, Coroflow, Ultreon |
| Shockwave Medical, INC | $650.22 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $470.54 | 2022-2025 | Eluvia, Ekosonic, Carotid Wallstent |
| Abiomed | $330.90 | 2022-2025 | Impella |
| Philips North America LLC | $240.62 | 2021-2023 | |
| Penumbra, INC. | $147.93 | 2022 | |
| Pfizer INC. | $123.37 | 2022-2024 | |
| Cardiovascular Systems INC. | $122.63 | 2021 | |
| Novartis Pharmaceuticals Corporation | $91.39 | 2023-2025 | |
| Avinger INC. | $71.59 | 2023 | Pantheris |
| Cvrx, INC. | $40.04 | 2024 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $31.16 | 2023-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $23.79 | 2022 | |
| Inspire Medical Systems, INC. | $23.54 | 2025 | Inspire |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.06 | 2022-2025 | Lifevest |
| Bard Peripheral Vascular, INC. | $20.25 | 2025 | Rotarexs 6 F X 135 Cm |
| Irhythm Technologies, INC. | $19.43 | 2023 | Zio Xt Patch |
| Lilly USA, LLC | $15.96 | 2025 | Zepbound, Mounjaro |
| Amgen INC. | $14.86 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $14.47 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $14.45 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Babar Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.